Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

A Randomized Controlled Study of Ropivacaine Combined With Hydromorphone to Block Lumbar Muscle in Elderly Inguinal Hernia Repair.

ID
Name
2022/148
Description
To compare the clinical and postoperative analgesic effects of hydromorphone combined with ropivacaine and ropivacaine alone in quadrangular muscle block for open inguinal hernia in elderly patients.
Trial arms
Trial start
2022-11-01
Estimated PCD
2023-11-30
Trial end
2023-12-25
Status
Completed
Treatment
Hydromorphone combined with ropivacaine
1mg hydromorphone was added to 0.375% ropivacaine for a total of 30ml to perform quadrat block
Arms:
Hydromorphone combined with ropivacaine
Other names:
Quadratus lumbois block
Ropivacaine
A mixture of 0.375% ropivacaine for a total of 30ml was used for quadrate block
Arms:
ropivacaine
Other names:
Quadratus lumbois block
Size
63
Primary endpoint
Related indexes of anesthesia effect: pain after surgery, 6, 12, 18,24, 48h after surgery.
From the end of surgery until two days after surgery.
Related indexes of anesthesia effect: time of onset of anesthesia, duration of anesthesia maintenance.
From the start of anesthesia until two days after surgery.
Eligibility criteria
Inclusion Criteria: * Age 60 and above. * Admission to hospital for open inguinal hernia surgery is consistent with the -indications of this surgical modality, ASA grades 1 to 3. * No recent use of sedatives, opioids, or other analgesics. * Good compliance, signed informed consent. * Complete clinical data. Exclusion Criteria: * There are serious cardiovascular and cerebrovascular diseases. * Abdominal infection. * Coagulation dysfunction or receiving anticoagulation therapy. * Local anesthesia drug allergy. * Can not cooperate with the corresponding operation, suffering from mental illness. * Previous surgical history of the corresponding position in the abdomen that may interfere with the surgical process of this study.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR']}}, 'enrollmentInfo': {'count': 63, 'type': 'ACTUAL'}}
Updated at
2024-01-23

1 organization

2 products

1 indication

Organization
Second Hospital of Jilin University
Product
Hydromorphone combined with Ropivacaine
Indication
Inguinal Hernia
Product
Ropivacaine